The U.S. Rosacea Market : Facts, Figures and Analytical Insights 2021-2024

The U.S. Rosacea Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Report analyses the post-COVID-19 (Corona Virus) impact on the product industry chain based on the upstream and downstream markets, on various regions and major countries and on the future development of the industry are pointed out.

Order a Copy of This Report (USD $850) at:

https://www.marketinsightsreports.com/report/purchase/04282009523?mode=su?Mode=S12    

The 56 pages report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global The U.S. Rosacea Market: Foamix Pharmaceuticals Ltd., Galderma, Sol-Gel Technologies Ltd., and Allergan Plc and others.

Industry News and Updates:

FDA approves first topical minocycline for rosacea

May 30, 2020: The U.S. Food and Drug Administration has approved FMX103 (ZILXI, Menlo Therapeutics), a topical 1.5% minocycline foam for the treatment of inflammatory lesions of rosacea in adult patients.

Another topical rosacea treatment enters the market with the United States Food and Drug Administration (FDA) approval of FMX103 (ZILXI, Menlo Therapeutics), a 1.5% minocycline foam, equipped with the company’s proprietary Molecule Stabilizing Technology (MST), for the treatment of inflammatory lesions of rosacea in adult patients.

Oral minocycline has been on the market for numerous years for acne vulgaris but is now being developed into a topical formulation to treat both acne and rosacea. Previously, a 4% topical minocycline foam (Amzeeq) developed by Menlo’s now wholly-owned subsidiary Foamix Pharmaceuticals Ltd. was approved by the FDA for treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in pediatric patients and adults on Oct. 18, 2019.

Galderma Launches New Rosacea Public Awareness Campaign

August 20, 2020: Face Up to Rosacea offers rosacea patients information to help them navigate their treatment journey, including skincare tips, treatment information, lifestyle hacks, dermatologist advice and stories from other people living with rosacea.

Galderma is partnering with rosacea patient and celebrity stylist Brad Goreski for the national awareness campaign, Face Up to Rosacea, to encourage people frustrated with this chronic skin condition to take action by consulting with a dermatologist.  Face Up to Rosacea offers rosacea patients information to help them navigate their treatment journey, including skincare tips, treatment information, lifestyle hacks, dermatologist advice and stories from other people living with rosacea.

Inquire More:

https://www.marketinsightsreports.com/reports/04282009523/the-u-s-rosacea-market-size-trends-forecasts-2020-2024-edition/inquiry?Mode=S12

Market Overview:

Rosacea is a common disorder associated with skin and most prevalent among people with light skin tone, and mainly affects areas around the chin, cheeks, nose, and forehead. The main characteristic of this disease is solid-bumps and pus-filled pimples.

Rosaceais a common chronic condition of the skin with a high prevalence rate among the U.S. population. It naturally begins at any time after the age of 30 or previously. In some cases, rosacea may also occur on the neck, chest, scalp or ears. Rosacea symptoms and signs include facial flushing, fine red vascular lines, swollen, red eyelids and many more. Currently, more than 16 million populations in the U.S. are suffering from rosacea.

The U.S. rosacea market has grown over the past few years and is projected to grow at a high growth rate on the back of rising incidence of disease, and aging population. The growth in the market will be driven by unhealthy eating habits and environmental factors, rising disposable income, ageing population, escalating healthcare expenditure, high prevalence of rosacea, etc. Yet the market growth is restrained by factors such as lack of awareness and knowledge and stringent government regulations for the approval of new drugs.

The research study evaluates the overall size of the market, by making use of a bottom-up approach, wherein data for different industry verticals, and end-user industries and its applications across various product types have been recorded and predicted during the forecast period. These segments and sub-segments have been documented from the industry specialists and professionals, as well as company representatives, and are outwardly validated by analyzing previous years’ data of these segments and sub-segments for getting an accurate and complete market size.                                            

Following are major Table of Content of The U.S. Rosacea Industry:

The U.S. Rosacea Market Sales Overview.
The U.S. RosaceaMarket Sales Competition by Manufacturers.
The U.S. Rosacea Market Sales Analysis by Region.
The U.S. Rosacea Market Sales Analysis by Type.
The U.S. Rosacea Market Analysis by Application.
The U.S. RosaceaMarket -Manufacturers Analysis.

Furthermore, this study will help our clients solve the following issues:

Cyclical dynamics - We foresee dynamics of industries by using core analytical and unconventional market research approaches. Our clients use insights provided by us to maneuver themselves through market uncertainties and interferences.

Identifying key cannibalizes - Strong substitute of a product or service is the most important threat. Our clients can identify key cannibalizes of a market, by procuring our research. This helps them in aligning their new product development/launch strategies in advance.

Spotting emerging trends – The report help clients to spot upcoming hot market trends. We also track possible impact and disruptions which a market would witness by a particular emerging trend. Our proactive analysis helps clients to have early mover advantage.

Interrelated opportunities - This report will allow clients to make decisions based on data, thereby increasing the chances that the strategies will perform better if not best in real world.

Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

Browse the report description and TOC:

https://www.marketinsightsreports.com/reports/04282009523/the-u-s-rosacea-market-size-trends-forecasts-2020-2024-edition?Mode=S12                                           

If you have any questions about any of our “The U.S. Rosacea market report” or would like to schedule a personalized free demo of The U.S. Rosacea market report, please do not hesitate to contact me at irfan@marketinsightsreports.com

Browse Related Reports:

Rosacea Treatments Market:

From US$ 1450.8 million in 2019, over the next five years the Rosacea Treatments market will register a 3.3% CAGR in terms of revenue, the global market size will reach US$ 1653.3 million by 2025.

https://www.marketinsightsreports.com/reports/02012579839/global-rosacea-treatments-market-growth-status-and-outlook-2021-2026?Mode=S12

Rosacea Medicine Market:

https://www.marketinsightsreports.com/reports/12152502832/global-rosacea-medicine-market-outlook-2021?Mode=S12

Contect Us:

Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.